Carbonic anhydrase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozymes I and II with some 1,3,4-oxadiazole-thiols

References

• Supuran CT, Scozzafava A, Conway J. Carbonic anhydrase. Its inhibitors and activators. CRC Press, London 2004
   Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003; 23: 146–189
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Exp Opin Ther Patents 2000; 10: 575–600
   Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. carbonic anhydrase. Its inhibitors and activators. CRC Press, London 2004; 1–23
   Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J Enz Inhib Med Chem 2004; 19: 199–229
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin Ther Pat 2004; 14: 667–702
   Web of Science ®Google Scholar
• Pastoreková S, Pastorek J. Cancer-related carbonic anhydrase isozymes and their inhibition. Carbonic anhydrase. Its inhibitors and activators. CRC Press, London 2004; 255–281
   Google Scholar
• Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992; 187: 620–626
   PubMed Web of Science ®Google Scholar
• Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int. J. Cancer 1993; 54: 268–274
   PubMed Web of Science ®Google Scholar
• Zavada J, Zavadova Z, Pastorek J, Biesova Z, Jezek J, Velek J. Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of the region mediating cell adhesion. Br. J. Cancer 2000; 82: 1808–1813
   PubMed Web of Science ®Google Scholar
• Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000; 6: 15–19
   PubMedGoogle Scholar
• Potter CPS, Harris AL. Diagnostics, prognostics and therapeutic implications of carbonic anhydrases in cancer. Brit J Cancer 2003; 89: 2–7
   PubMed Web of Science ®Google Scholar
• Supuran CT, Casini A, Scozzafava A. Development of carbonic anhydrase inhibitors. Carbonic anhydrase. Its inhibitors and activators. CRC Press, London 2004; 67–147
   Google Scholar
• Krungkrai J, Scozzafava A, Reungprapavut S, Krungkrai SR, Rattanajak R, Kamchonwongpaisan S, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: Towards antimalarials with a novel mechanism of action?. Bioorg Med Chem 2005; 13: 483–489
   PubMed Web of Science ®Google Scholar
• Suarez Covarrubias A, Larsson AM, Hogbom M, Lindberg J, Bergfors T, Bjorkelid C, Mowbray SL, Unge T, Jones TA. Structure and function of carbonic anhydrases from Mycobacterium tuberculosis. J Biol Chem 2005; 280: 18782–18789
   PubMed Web of Science ®Google Scholar
• Suarez Covarrubias A, Bergfors T, Jones TA, Hogbom M. Structural mechanics of the pH dependent activity of beta -carbonic anhydrase from Mycobacterium tuberculosis. J. Biol. Chem. 2006, in press
   Google Scholar
• Klengel T, Liang WJ, Chaloupka J, Ruoff C, Schroppel K, Naglik JR, Eckert SE, Mogensen EG, Haynes K, Tuite MF, Levin LR, Buck J, Muhlschlegel FA. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol 2005; 15: 2021–2026
   PubMed Web of Science ®Google Scholar
• Bahn YS, Cox GM, Perfect JR, Heitman J. Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence. Curr Biol 2005; 15: 2013–2020
   PubMed Web of Science ®Google Scholar
• Svastova E, Hulikova A, Rafajova M, Zat'ovicova M, Gibadulinova A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekova S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004; 577: 439–445
   PubMed Web of Science ®Google Scholar
• Cecchi A, Hulikova A, Pastorek J, Pastorekova S, Scozzafava A, Winum J-Y, Montero J-L, Supuran CT. Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis. J Med Chem 2005; 48: 4834–4841
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000; 60: 7075–7083
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT. Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Let 2004; 14: 869–873
   PubMed Web of Science ®Google Scholar
• Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastorekova S, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?. Bioorg Med Chem Lett 2005; 15: 963–969
   PubMed Web of Science ®Google Scholar
• Casey JR, Morgan PE, Vullo D, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J Med Chem 2004; 47: 2337–2347
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors: Aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors. J Enz Inhib 2000; 15: 597–610
   Google Scholar
• Abbate F, Casini A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: X ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors. J Enz Inhib Med Chem 2003; 18: 303–308
   PubMed Web of Science ®Google Scholar
• Abbate F, Casini A, Owa T, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg Med Chem Lett 2004; 14: 217–223
   PubMed Web of Science ®Google Scholar
• Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2 selective Celecoxib: New pharmacological opportunities due to related binding site recognition. J Med Chem 2004; 47: 550–557
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Briganti F, Ilies M, Supuran CT. Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfinamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J Med Chem 2000; 43: 292–300
   PubMed Web of Science ®Google Scholar
• Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2003; 13: 1005–1009
   PubMed Web of Science ®Google Scholar
• Innocenti A, Casini A, Alcaro AC, Papini AM, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: The first on-resin screening of a 4-sulfamoylphenylthiourea library. J Med Chem 2004; 47: 5224–5229
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971; 246: 2561–2573
   PubMed Web of Science ®Google Scholar
• Ladva K, Patel P, Upadhyay P, Parekh H. Synthesis and biological activities of substituted 1, 3, 4-oxadiazole derivatives. Ind. J Chem 1996; 35B: 1062
   Google Scholar
• Lai JYQ, Ferguson Y, Jones M. Preparation of substituted quinolinyl and isoquinolinyl sulfonyl chlorides for synthesis of novel sulfonamides. Synth. Commun. 2003; 33: 3427
   Web of Science ®Google Scholar
• Furniss BS, Hannaford AJ, Rogers V, Smith PWG, Tatchell AR. Vogel Textbook of Practical Organic Chemistry4^th ed. Longmann, London, a: pp 1135; b: pp 505; c: pp 1242
   Google Scholar
• Sun XW, Liang HT, Zhang ZY. Synthesis and antibacrerial activity of 4-aryl-1-(1-p-chlorophenyl-5-methyl-1,2,3-triazol-4-carbonyl)thiosemicarbazides and their related heterocyclic derivatives. Ind. J Chem 1999; 38B: 679
   Google Scholar
• Clare BW, Scozzafava A, Supuran CT. Protease inhibitors. Synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type. J Med Chem 2001; 44: 2253–2258
   PubMedGoogle Scholar
• Ahmad R, Iqbal R, Akhtar RH, Haq ZU, Duddeck H, Stefaniak L, Sitkowski J. Synthesis and structure determination of some oxadiazole-2-thione and triazole-3-thione galactosides. Nucleosides, Nucleotides and Nucleic Acids 2001; 20: 1671
   PubMed Web of Science ®Google Scholar
• Yousif MY, Ismail AM, Elman AA, El-Kerdawy MM. Synthesis of substituted Mercapto-1,2,4-triazoles and substituted 1,2,4-triazoles-5-ylmercaptomethyl-1,3,4-oxadiazoles as Antimicrobal Agents. J Chem Soc Pak 1986; 8: 183
   Web of Science ®Google Scholar
• Iqbal R, Zareef M, Zaidi JH, Khan KM, Arfan M, Masoudi NA. Synthesis, anti- HIV and anti-fungal activities of novel chiral and achiral sulfonamides bearing 1, 3, 4- oxadiazol-2-ylthio moiety. J Heterocyclic Chem submitted
   Google Scholar
• Supuran CT, Scozzafava A, Saramet I, Banciu MD. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes. J Enz Inhib 1998; 13: 177–194
   Google Scholar
• Scozzafava A, Saramet I, Banciu MD, Supuran CT. Carbonic anhydrase activity modulators: Synthesis of inhibitors and activators incorporating 2-subtituted-thiazol-4-yl-methyl scaffolds. J Enz Inhib 2001; 16: 351–358
   Google Scholar
• Almajan GL, Innocenti A, Puccetti L, Manole G, Barbuceanu S, Saramet I, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols. Biorg Med Chem Lett 2005; 15: 2347–2352
   PubMed Web of Science ®Google Scholar